| | |||||
| lung cancer | |||||
| 新闻 | |||||
| |||||
| EGFR vs. ALK: How molecular profiling defines lung cancer treatment - KevinMD.com ... lung cancer (NSCLC). This mutation leads to continuous activation of the EGFR tyrosine kinase domain, resulting in uncontrolled tumor growth. In ...
| |||||
| Chernobyl doctor found not reliable to testify in cancer case - Everett Post A Nebraska court struck his testimony in the case of a firefighter/engineer who developed lung cancer and Chronic Obstructive Pulmonary Disease when ...
| |||||
| |||||
| Immutep's LAG-3 hopes take a hit on Phase III NSCLC termination - Clinical Trials Arena ... lung cancer (NSCLC). This follows a recommendation from an independent data monitoring committee (IDMC), which warned Immutep that efti, a ...
| |||||
| A Case of Urethral Carcinoma With Cardiac Metastasis and Pulmonary Tumor Thrombotic ... Cardiac metastasis and pulmonary tumor thrombotic microangiopathy (PTTM) are uncommon, often fatal complications of malignancy, and are rarely ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment